FDA approves drug for postmenopausal symptoms
October 10th 2013The first drug combining estrogens with bazedoxifene has been approved by the U.S. Food and Drug Administration (FDA) for treatment of moderate-to-severe vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis.
Walking lowers breast cancer risk
October 10th 2013Postmenopausal women who walk at least 7 hours per week have a significantly lower risk of breast cancer than their less active counterparts. Those are the findings of a large epidemiologic study published in Cancer: Epidemiology Biomarkers & Prevention.
Does HRT raise risk of breast cancer in thin or obese women?
September 26th 2013A new registry-based study sheds light on patient factors that may influence risk of breast cancer associated with use of postmenopausal hormone replacement therapy (HRT)-including race, weight, and breast density. Findings from the report, published in The Journal of the National Cancer Institute, suggest the greatest association between HRT use and breast cancer in women with low/normal body mass index (BMI) and extremely dense breasts.
USPSTF updates guidelines on medication for breast cancer risk reduction
September 26th 2013In an update of its 2002 recommendation on use of medications for breast cancer risk reduction, the U.S. Preventive Services Task Force (USPSTF) is encouraging informed decision-making and cautioning against use of medications for prevention in women who are not at increased risk of the disease.